Clinical and Radiographic Evaluation of 3Mixtatin Versus MTA Used as Pulpotomy Agents in Vital Primary Molars: A Randomized Clinical Trial

3Mixtatin and MTA pulpotomy

The aim of the study is to evaluate clinical and radiographic success of using 3Mixtain versus mineral trioxide aggregate in pulpotomy of deeply carious Primary molars.

2024-08-01

2025-08-01

2025-09-01

Not yet recruiting

Early phase I

50

Inclusion Criteria: * • Children 4-8 years old * Vital deeply carious primary molars. * No history of spontaneous pain, pathologic mobility, draining sinus tract, redness or swelling of the vestibule. * Normal gingival and periodontal condition, with no sensitivity to vestibular palpation, and no pain on percussion test. * Patient and parent showing cooperation and compliance. Exclusion Criteria: * • Uncooperative children to avoid time waste and attrition bias. * Unrestorable molars * Sign of radiolucency in periapical or furcation area * Widening of PDL space or loss of lamina dura continuity * Evidence of internal/external pathologic root resorption * During operative procedure, when hemorrhage control is not achievable after pulpotomy. * Children with systemic disease as some systemic diseases may have effect on the outcome. * Unable to attend follow-up visits to avoid attrition bias by decreasing number of drop off cases. * Refusal of participation as the parent of child has the authority of participation.

{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE1'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 50, 'type': 'ESTIMATED'}}

2024-06-27